The Canadian Association of Paediatric Nephrologists feels that advocacy is an important part of the professional responsibility of our members. Over the years, we have linked with several key stakeholder organizations to develop advocacy tool kits and skills to help improve the lives our our patients. Our current initiatives involve medication access and formulary fairness for pediatric nephrology patients. We are aware that other issues that come up that require our voice to be heard. If there are issues from a patient or health care provider perspective, please contact us using the following advocacy request form.
Advocacy workshop (Baltimore May 2016)
Publications from CAPN on advocacy issues
Dionne JM, Harris KC, Benoit G, Feber J, Poirier L, Cloutier L, Nakhla M, Rabi D, Daskalopoulou SS, Fournier A for the Hypertension Canada Guideline Committee. Hypertension Canada’s 2017 Guidelines for the Diagnosis, Assessment, Prevention, and Treatment of Pediatric Hypertension. Can J Cardiol 2017;33:577-585.
Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, Dionne JM, Flinn SK, Falkner B, Gidding SS, Goodwin C , Leu MG, Powers ME, Rea C, Samuels J, Simasek M, Thaker VV, Urbina EM, for the Subcommittee on Screening and Management of High Blood Pressure in Children. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics 2017;140(3) e2017190